WHO ICTRP trial
Phase I/IIa clinical trial on the safety and preliminary efficacy of…
EUCTR2019-003362-41-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-003362-41-IT |
|---|---|
| Public title | Phase I/IIa clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation |
| Scientific title | Phase I/IIa clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation - Anti-leukemia T cell therapy after haplo-HSCT |
| Primary sponsor | FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Leukemia relapse prevention given haploidentical hematopoietic stem cell transplantation MedDRA version: 21.1 Level: PT Classification code 10000880 Term: Acute myeloid leukaemia System Organ Class: 10029104 - Neoplasms benign, malignant… |
| Interventions | Product Name: linfociti T citotossici anti-leucemia Product Code: [CTL anti-leucemia] Pharmaceutical Form: Suspension for injection Current Sponsor code: ND Concentration unit: IU/kg international unit(s)/kilogram Concentration type: range… |
| Registration date | Jul 10, 2020 |
| Target size | 15 |
| Secondary IDs | Leuk-CTL-001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: